Publication

Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance

Authored by:

Mackenzie, G. A., Hill, P. C., Jeffries, D. J., Ndiaye, M., Sahito, S. M., Hossain, I., ... & Mackenzie, R.

Full Citation:

Mackenzie, G. A., Hill, P. C., Jeffries, D. J., Ndiaye, M., Sahito, S. M., Hossain, I., ... & Mackenzie, R. 2021. Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance. The Lancet Infectious Diseases.

View Publication

Additional key concepts from this publication:

Use of vaccines, including strengthening existing immunization programs, provides opportunities for significant reductions in disease burden with resultant economic benefits.

Key Evidence: A surveillance study over a 10-year period in the Gambia found that routine introduction of PCV led to a 33% reduction in the incidence of radiological pneumonia and a 27% decline in pneumonia hospitalizations in children. Reducing the rate of pneumococcal disease will not only save lives but will also reduce the substantial economic burden placed on families and health systems.